Insulet Stock Today
| PODD Stock | USD 168.74 2.48 1.49% |
Performance0 of 100
| Odds Of DistressLess than 3
|
Insulet is trading at 168.74 as of the 18th of April 2024, a 1.49 percent increase since the beginning of the trading day. The stock's lowest day price was 165.1. Insulet has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Insulet are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 19th of March 2024 and ending today, the 18th of April 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 15th of May 2007 | Category Healthcare | Classification Health Care |
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts. Insulet Corp operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. The company has 70.02 M outstanding shares of which 3.12 M shares are at this time shorted by private and institutional investors with about 3.46 trading days to cover. More on Insulet
Moving together with Insulet Stock
| 0.79 | EMBC | Embecta Corp Financial Report 10th of May 2024 | PairCorr |
Moving against Insulet Stock
| 0.84 | ELMD | Electromed | PairCorr |
| 0.82 | FEMY | Femasys Financial Report 9th of May 2024 | PairCorr |
| 0.76 | ALC | Alcon AG Financial Report 14th of May 2024 | PairCorr |
| 0.76 | CAH | Cardinal Health Financial Report 2nd of May 2024 | PairCorr |
| 0.74 | BAX | Baxter International Sell-off Trend | PairCorr |
| 0.62 | GCTK | GlucoTrack | PairCorr |
| 0.58 | VMD | Viemed Healthcare Downward Rally | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 2nd of May 2024
Insulet Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Insulet's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Insulet or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO and President and Director | Patrick Sullivan | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Ideas | (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, SP 500 Index, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Baby Boomer Prospects, Obamacare Repeal, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Insulet report their recommendations after researching Insulet's financial statements, talking to executives and customers, or listening in on Insulet's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Insulet. The Insulet consensus assessment is calculated by taking the average forecast from all of the analysts covering Insulet. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to Insulet's liquidity, profitability, solvency, and operating efficiency, Insulet is doing better financially then in previous quarter. It has a moderate probability of reporting better financial numbers in May. Financial strength of Insulet is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Insulet's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Insulet's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Insulet's financial leverage. It provides some insight into what part of Insulet's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Insulet (PODD) is traded on NASDAQ Exchange in USA. It is located in 100 Nagog Park, Acton, MA, United States, 01720 and employs 3,000 people. Insulet is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 12.19 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Insulet's market, we take the total number of its shares issued and multiply it by Insulet's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Insulet conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 70.02 M outstanding shares of which 3.12 M shares are at this time shorted by private and institutional investors with about 3.46 trading days to cover.
Insulet currently holds about 708.6 M in cash with 145.4 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.21.
Check Insulet Probability Of Bankruptcy
Ownership AllocationInsulet secures a total of 70.02 Million outstanding shares. The majority of Insulet outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Insulet to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Insulet. Please pay attention to any change in the institutional holdings of Insulet as this could imply that something significant has changed or is about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check Insulet Ownership Details
Insulet Stock Price Odds Analysis
What are Insulet's target price odds to finish over the current price? Based on a normal probability distribution, the odds of Insulet jumping above the current price in 90 days from now is about 81.44%. The Insulet probability density function shows the probability of Insulet stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.3126 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Insulet will likely underperform. Additionally, insulet has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Insulet to move above the current price in 90 days from now is about 81.44 (This Insulet probability density function shows the probability of Insulet Stock to fall within a particular range of prices over 90 days) .
Insulet Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Insulet that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Insulet's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Insulet's value.| Instituion | Recorded On | Shares | |
| Baillie Gifford & Co Limited. | 2023-12-31 | 1.2 M | |
| Norges Bank | 2023-12-31 | 1 M | |
| Morgan Stanley - Brokerage Accounts | 2023-12-31 | 1 M | |
| D1 Capital Partners L.p. | 2023-12-31 | 1 M | |
| William Blair Investment Management, Llc | 2023-12-31 | 918.7 K | |
| Amvescap Plc. | 2023-12-31 | 744.6 K | |
| Westfield Capital Management Company, Lp | 2023-12-31 | 705.4 K | |
| Northern Trust Corp | 2023-12-31 | 666.6 K | |
| Ameriprise Financial Inc | 2023-12-31 | 654.7 K | |
| Capital Research Global Investors | 2023-12-31 | 9.5 M | |
| Vanguard Group Inc | 2023-12-31 | 8 M |
Insulet Historical Income Statement
Insulet Income Statement is one of the three primary financial statements used for reporting Insulet's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Insulet revenue and expense. Insulet Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Insulet's Operating Income is projected to increase significantly based on the last few years of reporting. The current year's EBIT is expected to grow to about 154.6 M, whereas Income Tax Expense is projected to grow to (7.9 M). View More FundamentalsInsulet Stock Against Markets
Picking the right benchmark for Insulet stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Insulet stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Insulet is critical whether you are bullish or bearish towards Insulet at a given time. Please also check how Insulet's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Insulet without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Headlines Timeline Now
Headlines TimelineStay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
| All Next | Launch Module |
Insulet Corporate Directors
Insulet corporate directors refer to members of an Insulet board of directors. The board of directors generally takes responsibility for the Insulet's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Insulet's board members must vote for the resolution. The Insulet board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Sally Crawford | Lead Independent Director | Profile | |
| John Fallon | Independent Director | Profile | |
| Daniel Levangie | Independent Director | Profile | |
| James Mullen | Independent Director | Profile |
How to buy Insulet Stock?
Before investing in Insulet, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Insulet. To buy Insulet stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Insulet. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Insulet stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Insulet stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Insulet stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Insulet, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Insulet Stock please use our How to Invest in Insulet guide.
Already Invested in Insulet?
The danger of trading Insulet is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Insulet is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Insulet. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Insulet is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Insulet is a strong investment it is important to analyze Insulet's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insulet's future performance. For an informed investment choice regarding Insulet Stock, refer to the following important reports: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Insulet. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.Note that the Insulet information on this page should be used as a complementary analysis to other Insulet's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for Insulet Stock analysis
When running Insulet's price analysis, check to measure Insulet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insulet is operating at the current time. Most of Insulet's value examination focuses on studying past and present price action to predict the probability of Insulet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insulet's price. Additionally, you may evaluate how the addition of Insulet to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |
Is Insulet's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insulet. If investors know Insulet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insulet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 5.043 | Earnings Share 2.93 | Revenue Per Share 24.331 | Quarterly Revenue Growth 0.379 | Return On Assets 0.0609 |
The market value of Insulet is measured differently than its book value, which is the value of Insulet that is recorded on the company's balance sheet. Investors also form their own opinion of Insulet's value that differs from its market value or its book value, called intrinsic value, which is Insulet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insulet's market value can be influenced by many factors that don't directly affect Insulet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insulet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insulet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insulet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.